Copaxone Alternatives Compared
| Copaxone | Gilenya | Tysabri |
|
|---|
| Copaxone glatiramer | Gilenya fingolimod | Tysabri natalizumab |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Copaxone is a combination of four amino acids that may be given to treat relapsing forms of multiple sclerosis in adults. It has been shown to significantly reduce the number of relapses, but may be... View more |
Gilenya is an immunosuppressant that may be used to treat relapsing forms of MS in adults and children over the age of 10. It can increase your risk of infection and interact with multiple drugs, and... View more |
Tysabri may be used to treat adults with multiple sclerosis or Crohn's disease and is given once every four weeks through an infusion center registered with the Touch Prescribing Program. A headache... View more |
Choose a suggestion below Multiple Sclerosis
|
|||||||||||||||||||||||
| More about Copaxone (glatiramer) | More about Gilenya (fingolimod) | More about Tysabri (natalizumab) | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
|||||||||||||||||||||||||
| Availability | ||||||||||||||||||||||||||
|
Prescription only |
Prescription only |
Prescription only |
||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Copaxone has an average rating of 7.7 out of 10 from a total of 127 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 14% reported a negative effect. |
Gilenya has an average rating of 7.0 out of 10 from a total of 92 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 19% reported a negative effect. |
Tysabri has an average rating of 7.8 out of 10 from a total of 96 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 16% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Common side effects include: anxiety, chest pain, dyspnea, lymphadenopathy, palpitations, post-injection flare, urticaria, vasodilation, flushing, erythema at injection site, induration at injection site, inflammation at injection site, itching at injection site, pain at injection site. See the full Copaxone side effects document. |
Common side effects include: infection, back pain, diarrhea, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased liver enzymes. See the full Gilenya side effects document. |
See the full Tysabri side effects document. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Copaxone prices and generic prices |
View all Gilenya prices |
View all Tysabri prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other glatiramer brands include: Glatopa | Other fingolimod brands include: Tascenso ODT |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
1 hour |
216 hours |
360 hours |
||||||||||||||||||||||||
| CSA Schedule** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category B
No proven risk in humans
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
Category C
Risk cannot be ruled out
See the full Pregnancy Warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 1 drugs are known to interact with Copaxone:
|
A total of 575 drugs are known to interact with Gilenya:
|
A total of 343 drugs are known to interact with Tysabri:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
December 20, 1996 |
September 21, 2010 |
November 23, 2004 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.